– December 6-10, 2024 | Los Angeles, CA –
Zy Therapeutics will be attending AES 2024 in Los Angeles to highlight its work toward developing a disease-modifying treatment for Sturge-Weber Syndrome, Tuberous Sclerosis Complex, and Neurocysticercosis. The team is looking forward to connecting with colleagues and potential partners during the event.
AES 2024 provides an important opportunity for experts and innovators in the field of epilepsy to share progress, exchange insights, and explore new avenues for collaboration. Zy Therapeutics is excited to contribute to this year’s discussions and continue advancing therapies that can make a meaningful impact for patients.
